As MPE samples are easier to be obtained than TILs in advanced osteosarcoma patients, MPE samples may be a potential source for adoptive CD8+ T cell therapy in osteosarcoma patients; however, clinical studies are warranted to evaluate the anti‐cancer activities of CD8+ T cells derived from MPE samples. This evidence concerns the gene CD8A and cancer.